Clinical trial Recruiting at 1 site Interventional Ages 20 to 50

Melatonin Gel in Immediate Molar Implants in the Back of the jaw

Official title: Clinical and Radiographic Assessment of the Osteogenic Effect of Melatonin in Immediate Implant Placement: A Pilot Randomized Clinical Trial.

Run by Future University in Egypt · NCT07869030 · Data updated 2026-11-12

In this small study, researchers test whether applying a 1% melatonin gel during immediate molar implant placement in the back of the lower jaw helps with healing and bone formation.

More Dental Implant trials

Quick facts

Study typeInterventional
Ages20 Years to 50 Years
SexAll
Enrollment16 (estimated)
SponsorFuture University in Egypt
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Cairo)
StatusRecruiting
StartedNovember 6, 2025
Main results expectedJune 2027
Study endsJune 2027
Registry record updatedOctober 15, 2026
Trial IDNCT07869030 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are healthy adults 20–50 needing immediate posterior mandibular molar implants, non-smokers or light smokers, and able to attend follow-ups.

Probably not a fit

Patients with systemic bone healing disorders, heavy smoking, or major wound-healing risks may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This pilot randomized trial compares immediate posterior mandible implants with or without a 1% melatonin gel in the socket. Participants are healthy adults aged 20–50 and are randomized to receive either the melatonin treatment or standard care, using customized healing abutments in both groups. The study looks at bone density and buccal bone thickness by CBCT, implant stability over several months, and soft-tissue healing to estimate variability and feasibility for future trials. It is conducted at Future University in Egypt with a total of 16 participants (8 per group).

Why it matters

Potential benefit: If successful, the melatonin gel could improve bone healing and implant stability after immediate mandibular implants.

How similar studies have gone: Previous work in related bone healing uses of melatonin show potential, but this exact protocol in immediate implant sockets is exploratory.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients aged 20-50 years.
* Indicated for extraction and immediate implant placement in the posterior mandibular molar region.
* Good oral hygiene and compliance with postoperative instructions.
* Non-smokers or light smokers (≤10 cigarettes/day).
* Patients who provide written informed consent and agree to attend follow-up visits.

Exclusion Criteria:

* Patients with systemic diseases affecting bone metabolism or wound healing (e.g., uncontrolled diabetes, osteoporosis).
* Heavy smokers (\>10 cigarettes/day).
* History of head and neck radiotherapy or chemotherapy.
* Pregnant or lactating women.
* Sites with acute infection, cystic lesions, or pathology.
* Bruxism or parafunctional habits.
* Use of medications affecting bone turnover (e.g., bisphosphonates, corticosteroids).
* Poor compliance or unwillingness to return for follow-up visits.

Where it's running

  • Department of Oral and Maxillofacial Surgery, Faculty of Oral and Dental Medicine - Future University in Egypt
    Cairo, Egypt
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.